1. Home
  2. PRMB vs SRRK Comparison

PRMB vs SRRK Comparison

Compare PRMB & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Primo Brands Corporation

PRMB

Primo Brands Corporation

HOLD

Current Price

$20.82

Market Cap

8.0B

Sector

N/A

ML Signal

HOLD

Logo Scholar Rock Holding Corporation

SRRK

Scholar Rock Holding Corporation

HOLD

Current Price

$54.81

Market Cap

6.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRMB
SRRK
Founded
1955
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
6.8B
IPO Year
2025
2018

Fundamental Metrics

Financial Performance
Metric
PRMB
SRRK
Price
$20.82
$54.81
Analyst Decision
Buy
Strong Buy
Analyst Count
9
13
Target Price
$24.00
$56.17
AVG Volume (30 Days)
4.1M
967.8K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
2.49%
N/A
EPS Growth
328.57
N/A
EPS
0.26
N/A
Revenue
$6,664,000,000.00
N/A
Revenue This Year
$2.34
N/A
Revenue Next Year
$3.56
$534.24
P/E Ratio
$84.19
N/A
Revenue Growth
29.34
N/A
52 Week Low
$14.36
$27.07
52 Week High
$26.21
$61.76

Technical Indicators

Market Signals
Indicator
PRMB
SRRK
Relative Strength Index (RSI) 37.82 49.26
Support Level $17.90 $44.26
Resistance Level $21.33 $58.49
Average True Range (ATR) 0.87 2.36
MACD -0.18 -0.35
Stochastic Oscillator 16.02 9.47

Price Performance

Historical Comparison
PRMB
SRRK

About PRMB Primo Brands Corporation

Primo Brands Corp is a North American branded beverage company focused on healthy hydration. It delivers sustainably and domestically sourced diversified offerings across products, formats, channels, price points, and consumer occasions, distributed in every state and Canada. Primo Brands is in reusable packaging, helping to reduce waste through its reusable, multi-serve bottles and brand packaging portfolio, which includes recycled plastic, aluminum, and glass.

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.

Share on Social Networks: